PDC*line Pharma
Founded Year
2014Stage
Grant | AliveTotal Raised
$46.73MLast Raised
$6.6M | 1 yr agoAbout PDC*line Pharma
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens.
Missing: PDC*line Pharma's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: PDC*line Pharma's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing PDC*line Pharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
PDC*line Pharma is included in 3 Expert Collections, including Cancer.
Cancer
4,784 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
PDC*line Pharma Patents
PDC*line Pharma has filed 1 patent.
The 3 most popular patent topics include:
- Clusters of differentiation
- Cytokines
- Immune system
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/23/2019 | Immunology, Clusters of differentiation, Immune system, Interleukins, Cytokines | Application |
Application Date | 10/23/2019 |
|---|---|
Grant Date | |
Title | |
Related Topics | Immunology, Clusters of differentiation, Immune system, Interleukins, Cytokines |
Status | Application |
PDC*line Pharma Frequently Asked Questions (FAQ)
When was PDC*line Pharma founded?
PDC*line Pharma was founded in 2014.
Where is PDC*line Pharma's headquarters?
PDC*line Pharma's headquarters is located at 29 avenue du Maquis du Grésivaudan, Grenoble.
What is PDC*line Pharma's latest funding round?
PDC*line Pharma's latest funding round is Grant.
How much did PDC*line Pharma raise?
PDC*line Pharma raised a total of $46.73M.
Who are the investors of PDC*line Pharma?
Investors of PDC*line Pharma include Noshaq, Walloon Region, UTC Investment, Sambrinvest, Societe Regionale d'Investissement de Wallonie and 16 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.